LT
Land Therapeutics Inc.
SEC filingPharmaceuticals · Charlestown, MA
Amount raised$17.5Msold at filing
Total offering$92.1M$74.6M still open
Investors in the raise12count reported to the SEC
FiledOct 21, 2026first sale Dec 23, 2024
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Tony HoExecutive Officer, Director
Rob HopfnerDirector
Timothy ShannonDirector
Joe CabralDirector
Andy MayDirector
Dan PeerDirector
Executive officers, directors and promoters as listed on the Form D.